St. Joseph Aspirin Chewable Tablets Recall Lawsuit

On January 15, 2010 the U.S. Food and Drug Administration (FDA) in association with McNeil Consumer Healthcare issued a nationwide recall of St. Joseph Aspirin Chewable Tablets.

If you or somebody you know has been injured or suffered an economic loss from St. Joseph Aspirin Chewable Tablets, you should contact our law firm immediately. You may be entitled to compensation and our lawyers can help.

What’s the problem?

St. Joseph Aspirin Chewable Tablets were recalled because of consumer reports of an unusual moldy, musty, or mildew-like odor caused by the presence of trace amounts of a chemical called 2,4,6-tribromoanisole (TBA) that was associated with temporary and non-serious gastrointestinal events. According to the FDA, McNeil Consumer Healthcare has received a number of reports of mild illnesses.

The recall involves St. Joseph Aspirin Chewable Tablets in Orange flavor that were packaged in 36 count packages marked with UPC code 300450173362 and 3X36 count packages marked with UPC code 300450173089.

The St. Joseph Aspirin Chewable Tablets were distributed through various retailers nationwide and manufactured in the United States.

Do I Have A St. Joseph Aspirin Chewable Tablets Recall Lawsuit?

The Product Liability Litigation Group at our law firm is an experienced team of trial lawyers that focus exclusively on the representation of plaintiffs in defective consumer product lawsuits. We are currently evaluating potential St. Joseph Aspirin Chewable Tablets lawsuits in all 50 states.

Again, if you or somebody you know has been injured or suffered an economic loss from St. Joseph Aspirin Chewable Tablets, you should contact our law firm immediately. You may be entitled to compensation and our lawyers can help.